LE-SN38: Phase I data

In a U.S. Phase I trial in 68 patients LE-SN38 was well tolerated

Read the full 130 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE